Benzodiazepine Discontinuation in Opioid Agonist Therapy
NCT04109118
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Substance Use Disorders
Interventions
BEHAVIORAL:
Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
DRUG:
BZD discontinuation protocol
Sponsor
Boston Medical Center
Collaborators
[object Object]